Carvacrol/Thymol Composition For The Treatment Of Salmonid Rickettsial Septicemia And Infectious Salmon Anemia

Patent No. EP2552431 (titled "Carvacrol/Thymol Composition For The Treatment Of Salmonid Rickettsial Septicemia And Infectious Salmon Anemia") was filed by Ewos Innovation on Mar 28, 2011. The application was issued on Jun 14, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
NUTRECO ASSETSMar 12, 2018BECK GREENER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2552431

EWOS INNOVATION
Application Number
EP11717046A
Filing Date
Mar 28, 2011
Status
Granted And Under Opposition
May 12, 2017
Publication Date
Jun 14, 2017